Skip to search formSkip to main contentSkip to account menu

AMI 25

Known as: AMI-25, AMI25 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ferumoxides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI
Contrast agents, such as iron oxide, enhance MR images by altering the relaxation times of tissues in which the agent is present… 
2002
2002
An evaluation of the contributions of diffusion and exchange in relaxation enhancement by MRI contrast agents.
Review
1998
Review
1998
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
Abstract. A variety of parenterally administered iron oxides have been developed for contrast-enhanced MRI of the liver. Two… 
Highly Cited
1996
Highly Cited
1996
Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
PURPOSE To assess AMI-25- versus gadolinium-enhanced magnetic resonance (MR) imaging in the differential diagnosis of liver… 
Highly Cited
1995
Highly Cited
1995
Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
  • C. W. Jung
  • Magnetic resonance imaging
  • 1995
  • Corpus ID: 42576183
Highly Cited
1994
Highly Cited
1994
Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25.
PURPOSE To evaluate the ability of magnetic resonance (MR) imaging enhanced with AMI-25 to depict and characterize hepatic tumors… 
Highly Cited
1990
Highly Cited
1990
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
An ultrasmall superparamagnetic iron oxide (USPIO) preparation was developed that is small enough to migrate across the capillary… 
Highly Cited
1990
Highly Cited
1990
Assessment of a superparamagnetic iron oxide (ami‐25) as a brain contrast agent
We have applied a superparamagnetic iron oxide formulation (AMI‐25, Advanced Magnetics, Inc., Cambridge, MA) to image the… 
Highly Cited
1990
Highly Cited
1990
Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors.
Previous studies of AMI-25, a particulate iron oxide magnetic resonance contrast agent, imaged liver tumors 1 or more hours after… 
Highly Cited
1989
Highly Cited
1989
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
The pharmacokinetics (distribution, metabolism, bioavailability, excretion) and toxicity (acute and subacute toxicity… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License